Skip to main content

COVID-19 Topic Center

Interactive Features

First Report Managed Care
Sarah Temkin, MD, board-certified gynecologic oncologist, and Don Dizon, MD, oncologist specializing in women’s cancers, discuss an ongoing Phase III trial that examines the use of selinexor for the treatment of endometrial cancer, and highlight what they hope to see for the future of care.…
Back to Top